Antonio Uccelli

25.9k total citations · 4 hit papers
236 papers, 16.7k citations indexed

About

Antonio Uccelli is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Antonio Uccelli has authored 236 papers receiving a total of 16.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Pathology and Forensic Medicine, 62 papers in Immunology and 57 papers in Neurology. Recurrent topics in Antonio Uccelli's work include Multiple Sclerosis Research Studies (88 papers), Mesenchymal stem cell research (44 papers) and Peripheral Neuropathies and Disorders (32 papers). Antonio Uccelli is often cited by papers focused on Multiple Sclerosis Research Studies (88 papers), Mesenchymal stem cell research (44 papers) and Peripheral Neuropathies and Disorders (32 papers). Antonio Uccelli collaborates with scholars based in Italy, United States and United Kingdom. Antonio Uccelli's co-authors include Vito Pistoia, Lorenzo Moretta, Gianluigi Mancardi, Federica Benvenuto, Debora Giunti, Alice Laroni, Nicole Kerlero de Rosbo, Francesco Frassoni, Simona Casazza and Francesca Gualandi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature reviews. Immunology.

In The Last Decade

Antonio Uccelli

222 papers receiving 16.3k citations

Hit Papers

Mesenchymal stem cells in health and disease 2005 2026 2012 2019 2008 2005 2005 2009 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mesenchymal stem cells in health and disease
    2008 2.9k citations Antonio Uccelli et al. profile →
  2. Human mesenchymal stem cells modulate B-cell functions
    2005 1.4k citations Federica Benvenuto, Debora Giunti et al. profile →
  3. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
    2005 1.1k citations Federica Benvenuto, Debora Giunti et al. profile →
  4. C-C chemokine receptor 6–regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE
    2009 929 citations Federica Benvenuto, Antonio Uccelli et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Uccelli Italy 58 7.5k 4.2k 3.8k 3.4k 2.8k 236 16.7k
Amy J. Wagers United States 75 5.4k 0.7× 15.9k 3.8× 7.0k 1.8× 1.0k 0.3× 5.0k 1.8× 172 30.8k
Urban Lendahl Sweden 79 2.1k 0.3× 15.4k 3.7× 1.6k 0.4× 878 0.3× 2.6k 0.9× 215 24.8k
Mariusz Z. Ratajczak United States 82 6.6k 0.9× 15.3k 3.7× 6.3k 1.6× 718 0.2× 3.8k 1.4× 583 28.2k
Ralf H. Adams Germany 82 1.7k 0.2× 14.9k 3.5× 2.4k 0.6× 553 0.2× 2.5k 0.9× 212 25.8k
Simon J. Conway United States 75 1.2k 0.2× 10.5k 2.5× 5.0k 1.3× 611 0.2× 3.2k 1.1× 215 22.7k
Shahin Rafii United States 99 5.8k 0.8× 21.4k 5.1× 6.1k 1.6× 1.4k 0.4× 4.8k 1.7× 304 39.1k
Paul S. Frenette United States 81 7.9k 1.1× 7.9k 1.9× 9.9k 2.6× 390 0.1× 2.1k 0.7× 191 30.1k
Massimo Dominici Italy 50 14.9k 2.0× 7.7k 1.8× 1.7k 0.4× 691 0.2× 8.1k 2.9× 282 24.3k
Takayuki Asahara Japan 73 8.5k 1.1× 25.9k 6.2× 2.9k 0.8× 1.1k 0.3× 10.4k 3.7× 262 38.2k
Mark F. Pittenger United States 30 19.6k 2.6× 11.6k 2.8× 1.8k 0.5× 910 0.3× 11.6k 4.1× 46 32.3k

Countries citing papers authored by Antonio Uccelli

Since Specialization
Citations

This map shows the geographic impact of Antonio Uccelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Uccelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Uccelli more than expected).

Fields of papers citing papers by Antonio Uccelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Uccelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Uccelli. The network helps show where Antonio Uccelli may publish in the future.

Co-authorship network of co-authors of Antonio Uccelli

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Uccelli. A scholar is included among the top collaborators of Antonio Uccelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Uccelli. Antonio Uccelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davies, Lindsay C., Lucie Biard, Damián García‐Olmo, et al.. (2025). Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases. Cytotherapy. 27(11). 1326–1337. 1 indexed citations
2.
Malaguti, Maria Chiara, Monica Moroni, Marco Chierici, et al.. (2025). Machine Learning Predicts Risk of Falls in Parkison's Disease Patients in a Multicenter Observational Study. European Journal of Neurology. 32(5). e70118–e70118. 1 indexed citations
3.
Silvestri, Giulia, Luca Roccatagliata, Simona Schiavi, et al.. (2025). The “central vein sign” to differentiate multiple sclerosis from migraine. Headache The Journal of Head and Face Pain. 65(4). 558–567. 1 indexed citations
4.
Benamar, Mehdi, Paola Contini, Klaus Schmitz‐Abe, et al.. (2025). Notch3+ regulatory T cells drive autoimmune neuroinflammation in multiple sclerosis 2040. The Journal of Immunology. 214(Supplement_1).
5.
Escelsior, Andrea, et al.. (2025). Sleep abnormalities in mouse models of depression: a systematic review. Sleep Medicine Reviews. 84. 102179–102179.
6.
Cellerino, Maria, et al.. (2024). Brief international cognitive assessment for MS (BICAMS) and NEDA maintenance in MS patients: A 2‐year follow‐up longitudinal study. European Journal of Neurology. 32(1). e70007–e70007.
7.
Massa, Federico, Tiziana Vigo, Debora Giunti, et al.. (2024). COVID-19-associated serum and cerebrospinal fluid cytokines in post- versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome. Neurological Sciences. 45(3). 849–859. 2 indexed citations
8.
Massa, Federico, Samir Abu‐Rumeileh, Lorenzo Barba, et al.. (2023). Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease. Journal of Neurology. 271(4). 1999–2009. 4 indexed citations
9.
Masala, Alessandro, Maria Cellerino, Aldo Vagge, et al.. (2022). Choroidal Thickness in Multiple Sclerosis: An Optical Coherence Tomography Study. Journal of Clinical Neurology. 18(3). 334–334. 4 indexed citations
10.
Massa, Federico, Diego Franciotta, Stefano Grisanti, et al.. (2022). Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments. Neurological Sciences. 43(11). 6441–6447.
11.
Bäcker‐Koduah, Priscilla, Carmen Infante‐Duarte, Federico Ivaldi, et al.. (2020). Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS. Annals of Clinical and Translational Neurology. 7(9). 1628–1641. 8 indexed citations
12.
Bassi, Mario Stampanoni, Fabio Buttari, Ilaria Simonelli, et al.. (2020). A Single Nucleotide ADA Genetic Variant Is Associated to Central Inflammation and Clinical Presentation in MS: Implications for Cladribine Treatment. Genes. 11(10). 1152–1152. 6 indexed citations
13.
Laroni, Alice, Irene Schiavetti, Maria Pia Sormani, & Antonio Uccelli. (2020). COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments. Multiple Sclerosis Journal. 27(14). 2126–2136. 25 indexed citations
14.
Carmisciano, Luca, Alessio Signori, Matteo Pardini, et al.. (2020). Assessing upper limb function in multiple sclerosis using an engineered glove. European Journal of Neurology. 27(12). 2561–2567. 6 indexed citations
15.
Signori, Alessio, Maria Pia Sormani, Caterina Lapucci, et al.. (2019). Effects of aging on finger movements in multiple sclerosis. Multiple Sclerosis and Related Disorders. 37. 101449–101449. 3 indexed citations
16.
Pardini, Matteo, Giulia Bommarito, Luca Roccatagliata, et al.. (2019). CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS. Multiple Sclerosis and Related Disorders. 31. 93–96. 10 indexed citations
17.
Bos, Steffan D., Friedemann Paul, Antonio Uccelli, et al.. (2019). Sys4MS: Multiple sclerosis genetic burden score in a systems biology study of MS patients from four countries. European Journal of Neurology. 26. 1 indexed citations
18.
Laroni, Alice, Davide Brogi, Vincenzo Brescia Morra, et al.. (2016). Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy. Neurological Sciences. 38(1). 53–59. 20 indexed citations
19.
Sessarego, Nadia, Alessandro Parodi, Marina Podestà, et al.. (2008). Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application. Haematologica. 93(3). 339–346. 130 indexed citations
20.
Brok, Herbert, Antonio Uccelli, Nicole Kerlero de Rosbo, et al.. (2000). Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24–36 Is Presented by a Monomorphic MHC Class II Molecule. The Journal of Immunology. 165(2). 1093–1101. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amy J. Wagers Breakdown of academic impact, for papers by Urban Lendahl Breakdown of academic impact, for papers by Mariusz Z. Ratajczak Breakdown of academic impact, for papers by Ralf H. Adams Breakdown of academic impact, for papers by Simon J. Conway Breakdown of academic impact, for papers by Shahin Rafii Breakdown of academic impact, for papers by Paul S. Frenette Breakdown of academic impact, for papers by Massimo Dominici Breakdown of academic impact, for papers by Takayuki Asahara Breakdown of academic impact, for papers by Mark F. Pittenger
Rankless by CCL
2026